Year-end Sale % OFF 
Abstract
International Journal of Pharmacology and Clinical Sciences,2021,10,1,20-27.DOI:10.5530/ijpcs.2021.10.4Published:March 2021Type:Research ArticleAuthors:Yousef Ahmed Alomi, Nouf Hassan Alamoudi, Sabah Alanazi, and Abeer Hussin Almasoudi Author(s) affiliations:Yousef Ahmed Alomi* , BSc. Pharm, MSc. Clin Pharm, BCPS, BCNSP, DiBA, CDE Critical care clinical pharmacists, TPN clinical pharmacist, Freelancer Business Planner, Content Editor and Data Analyst, Riyadh, SAUDI ARABIA. Nouf Hassan Alamoudi, PharmD Umm Al-Qura University, Makkah, SAUDI ARABIA. Sabah Alanazi, B.D.S Prince Sultan Medical Military City, Riyadh, SAUDI ARABIA. Abeer Hussin Almasoudi, BSc.Pharm Director, Administration of research and studies, Ministry of Health, Tabuk, SAUDI ARABIA. Abstract:Objectives: Spontaneous reporting systems are indispensable as they aid perceive serious unknown adverse drug reaction (ADR). To assess the physician’s perceptions and attitudes of adverse drug reaction reporting in the Kingdom of Saudi Arabia. Methods: It was a cross-sectional study with an authenticated survey distributed to different physicians and dentists in Saudi Arabia. A self-administered electronic survey involved of demographic data and perception of the ADR reporting system and factor facilitated or prevented reporting system. Results: The total number of participants was 151. Of those, 111 (73.5%) were physicians, while dentists were 39 (26.5%). The average score physician’s perception about the prominence of the ADR reporting system was 4.46, with a statistically noteworthy difference within answers of each component (p<0.05). The average score of the physician’s perception of factors that enabled the ADR reporting system was 4.13 with a statistically momentous difference within answers of each component (p<0.05). The average scores of perception physicians were 3.13, with a statistically significant difference between the responses of each facet (p<0.05). Conclusion: The physicians’ perception of ADR and related issues was optimistic. The physicians request periodic training of ADR identification and reporting program. The pharmacist plays a perilous responsibility to improve the ADR system with healthcare providers. Keywords:Adverse drug reaction, Attitude, Perception, Physician, Reporting, Saudi ArabiaView:PDF (291.66 KB) PDFClick here to download the PDF file. Images Attitude and Perception of Physicians towards Adverse Drug Reaction Reporting in Saudi Arabia
Highlights
In 1969, the WHO well-defined Adverse Drug Reactions (ADRs) as any noxious unintended reaction to a drug which happen at normal doses employed in the prophylaxis, diagnosis or the treatment of diseases
In Jeddah city, 337 hospital physicians participant; the results showed that 90% of them had a positive attitude toward ADRs, ADRs reporting and monitoring system.[5]
The survey contained of several parts of perception of the ADR reporting system’s aids, factors inspiring to report ADR and barriers discourage reporting of ADR with reviewed by expert reviewers & showed pilot study and usage of various reliability test
Summary
In 1969, the WHO well-defined Adverse Drug Reactions (ADRs) as any noxious unintended reaction to a drug which happen at normal doses employed in the prophylaxis, diagnosis or the treatment of diseases. Over the past twenty years, more than forty studies have deliberated ADR reporting or pharmacovigilance and physicians’ perceptions. Various reason depresses reporting; for instance, did not know how to report 26-60% or dearth time 29-50%.[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24] Many studies were conducted to assess perception or attitude toward ADR reporting or pharmacovigilance between healthcare professionals in Saudi Arabia. At King Saud medical city, Riyadh 399 participants (52 physicians of participants), the results specify to 93.8% of all participants decided that ADR reporting should be made required for healthcare professionals and 94.5% settled that it improves patient safety.[9]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Pharmacology and Clinical Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
